Variables associated with pulmonary hypertension screened by echocardiography in chronic myeloid leukemia patients on dasatinib therapy

BACKGROUND: Pulmonary hypertension (PH) is a rare but life-threatening adverse event (AE) of dasatinib, but the associated variables are not clear. This study aimed to explore the variables associated with PH by echocardiography in patients with chronic myeloid leukemia in the chronic phase (CML-CP)...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Wenying, Yang, Sen, Yu, Chao, Zhu, Tiangang, Jiang, Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395681/
https://www.ncbi.nlm.nih.gov/pubmed/36017102
http://dx.doi.org/10.3389/fcvm.2022.960531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395681/
https://www.ncbi.nlm.nih.gov/pubmed/36017102
http://dx.doi.org/10.3389/fcvm.2022.960531

Ejemplares similares